The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,458,596 in first-year total cost, median $596,966.
Most frequent study sections
- Arthritis, Connective Tissue and Skin Study Section[ACTS]1
- Cancer Immunopathology and Immunotherapy Study Section[CII]1
- Gastrointestinal Mucosal Pathobiology Study Section[GMPB]1
- Xenobiotic and Nutrient Disposition and Action Study Section[XNDA]1
Most frequent institutions
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE1
- ROCKEFELLER UNIVERSITY1
- STANFORD UNIVERSITY1
- UNIVERSITY OF UTAH1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | Microbiota-based probiotics to treat inborn errors in metabolism1R01AT011396-01A1 | DODD, DYLAN | STANFORD UNIVERSITY, CA | $587,879 | XNDA |
| 2021 | Microbiota-immune interactions that promote intestinal homeostasis1R01AT011423-01A1 | ROUND, JUNE LOUISE | UNIVERSITY OF UTAH, UT | $606,053 | GMPB |
| 2020 | Translation of commensal bacteria mechanism for immunotherapy1R01CA245292-01 | HANG, HOWARD C | ROCKEFELLER UNIVERSITY, NY | $530,298 | CII |
| 2019 | Employing the gut microbiome to accelerate effective initiation of rheumatoid arthritis therapy1R01AR074500-01A1 | SCHER, JOSE U.TURNBAUGH, PETER JAMES | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $734,366 | ACTS |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.